Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 624.75M | $ -66.94M | -10.71% |
3/31/2025 | $ 631.94M | $ -44.25M | -7% |
12/31/2024 | $ 656.2M | $ -18.9M | -2.88% |
9/30/2024 | $ 645.12M | $ -16.39M | -2.54% |
6/30/2024 | $ 651.37M | $ -10.93M | -1.68% |
3/31/2024 | $ 652.68M | $ -4.89M | -0.75% |
12/31/2023 | $ 648.44M | $ 2.51M | 0.39% |
9/30/2023 | $ 641.61M | $ 11.77M | 1.83% |
6/30/2023 | $ 641.68M | $ 14.9M | 2.32% |
3/31/2023 | $ 644.53M | $ 15.96M | 2.48% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for VANDA PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ 19.36M ] / Assets [ $ 515.9M ]
(=) ROA [ 3.75% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.45K |
---|---|
min | -33.42% |
max | 33.98% |
average | 0.09% |
median | 1.53% |
std | 10.64% |